DEFB135
gene geneOn this page
Summary
DEFB135 (defensin beta 135, HGNC:32400) is a protein-coding gene on chromosome 8p23.1, encoding Beta-defensin 135 (Q30KP9). Has antibacterial activity.
Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 8p23.
Source: NCBI Gene 613209 — RefSeq curated summary.
At a glance
- GWAS associations: 21
- Clinical variants (ClinVar): 31 total — 1 pathogenic
- MANE Select transcript:
NM_001033017
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32400 |
| Approved symbol | DEFB135 |
| Name | defensin beta 135 |
| Location | 8p23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000205883 |
| Ensembl biotype | protein_coding |
| Entrez | 613209 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382208
RefSeq mRNA: 1 — MANE Select: NM_001033017
NM_001033017
CCDS: CCDS43710
Canonical transcript exons
ENST00000382208 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001491221 | 11984421 | 11984590 |
| ENSE00001491222 | 11982256 | 11982384 |
Expression profiles
Bgee: expression breadth broad, 81 present calls, max score 94.42.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0037 / max 6.2793, expressed in 1 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 87450 | 0.0037 | 1 |
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.42 | silver quality |
| granulocyte | CL:0000094 | 53.37 | gold quality |
| bone marrow cell | CL:0002092 | 40.41 | gold quality |
| ganglionic eminence | UBERON:0004023 | 39.09 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| corpus callosum | UBERON:0002336 | 35.69 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 34.35 | gold quality |
| bone marrow | UBERON:0002371 | 33.91 | gold quality |
| muscle tissue | UBERON:0002385 | 33.62 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| urinary bladder | UBERON:0001255 | 31.05 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.44 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prostate gland | UBERON:0002367 | 29.00 | gold quality |
| frontal cortex | UBERON:0001870 | 28.74 | gold quality |
| left testis | UBERON:0004533 | 28.66 | gold quality |
| temporal lobe | UBERON:0001871 | 28.65 | gold quality |
| amygdala | UBERON:0001876 | 28.60 | gold quality |
| leukocyte | CL:0000738 | 28.57 | gold quality |
| testis | UBERON:0000473 | 28.27 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| right atrium auricular region | UBERON:0006631 | 27.58 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| pancreas | UBERON:0001264 | 27.44 | gold quality |
| monocyte | CL:0000576 | 27.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The protein encoded by this gene is thought to display antimicrobial activity. (PMID:16033865)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb30 | ENSMUSG00000075571 |
| rattus_norvegicus | Defb30 | ENSRNOG00000038758 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 135 — Q30KP9 (reviewed: Q30KP9)
Alternative names: Defensin, beta 135
All UniProt accessions (1): Q30KP9
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001028189* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
| IPR050544 | Beta-defensin | Family |
Pfam: PF13841
UniProt features (5 total): disulfide bond 3, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q30KP9-F1 | 86.04 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 37–64, 44–58, 48–65
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 17 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOBP_CELL_KILLING, GOBP_RESPONSE_TO_BACTERIUM, FOSTER_KDM1A_TARGETS_UP, REACTOME_ANTIMICROBIAL_PEPTIDES, SUPT16H_TARGET_GENES, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM, WP_8P231_COPY_NUMBER_VARIATION_SYNDROME, GOMF_MEMBRANE_DESTABILIZING_ACTIVITY, REACTOME_DEFENSINS, REACTOME_BETA_DEFENSINS
GO Biological Process (4): innate immune response (GO:0045087), defense response to Gram-negative bacterium (GO:0050829), defense response (GO:0006952), defense response to bacterium (GO:0042742)
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| immune response | 1 |
| defense response to symbiont | 1 |
| defense response to bacterium | 1 |
| response to stress | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
147 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB135 | DEFB134 | Q4QY38 | 822 |
| DEFB135 | DEFB124 | Q8NES8 | 801 |
| DEFB135 | DEFB128 | Q7Z7B8 | 769 |
| DEFB135 | DEFB125 | Q8N687 | 768 |
| DEFB135 | DEFB127 | Q9H1M4 | 672 |
| DEFB135 | ZNF705D | P0CH99 | 654 |
| DEFB135 | DEFB114 | Q30KQ6 | 645 |
| DEFB135 | FAM86B1 | Q8N7N1 | 577 |
| DEFB135 | DEFB121 | Q5J5C9 | 571 |
| DEFB135 | C16orf95 | Q9H693 | 506 |
| DEFB135 | DEFB130A | P0DP74 | 491 |
| DEFB135 | DEFB118 | Q96PH6 | 400 |
| DEFB135 | FAM86B2 | P0C5J1 | 373 |
| DEFB135 | DEFB129 | Q9H1M3 | 369 |
| DEFB135 | IARS1 | P41252 | 359 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DEFB135 | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (41): CACNA2D1 (Affinity Capture-MS), COL6A2 (Affinity Capture-MS), CHRNA5 (Affinity Capture-MS), ATRN (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), ATRNL1 (Affinity Capture-MS), VWDE (Affinity Capture-MS), SP3 (Affinity Capture-MS), CD109 (Affinity Capture-MS), SEMA4F (Affinity Capture-MS), TMEM67 (Affinity Capture-MS), CTBS (Affinity Capture-MS), GPR98 (Affinity Capture-MS), MANBA (Affinity Capture-MS), TCTN2 (Affinity Capture-MS)
ESM2 similar proteins: A2A5H7, A4H202, A4H203, A4H204, A4H225, A4H226, A4H227, A4H228, A4H253, A4H254, A4H255, P50704, P50705, P50707, P50708, P50713, P50714, Q30KJ3, Q30KJ7, Q30KK8, Q30KN4, Q30KP9, Q30KT5, Q32P86, Q32ZF7, Q32ZG2, Q32ZG3, Q32ZH2, Q32ZH6, Q3UW41, Q5DQQ6, Q5G865, Q5G866, Q5IAB9, Q5J602, Q6IE40, Q6IE41, Q6IV18, Q7Z7B8, Q8IUB3
Diamond homologs: Q30KJ4, Q30KN4, Q30KP9, Q32ZG2, Q5J5Z9, Q30KK4, Q30KN8, Q32P86, Q32ZG7, Q8NES8, A4H220, A4H221, A4H222, A4H223, A4H225, A4H226, A4H227, A4H228, A4H235, A4H236, Q30KK5, Q30KK6, Q30KK9, Q5J5C9, Q5J5D0, Q5J600, Q5J602, Q8K3I8, Q8N688, Q8N690, Q95LI0, Q96PH6, A4H213, A4H211, A4H212, A4H253, A4H254, A4H255, Q30KL1, Q30KQ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 563538 | GRCh37/hg19 8p23.1(chr8:8093169-11935465)x1 | Pathogenic |
SpliceAI
138 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:11984416:GGCA:G | acceptor_loss | 0.9900 |
| 8:11984417:GCAG:G | acceptor_loss | 0.9900 |
| 8:11984418:CAG:C | acceptor_loss | 0.9900 |
| 8:11984420:GGTA:G | acceptor_gain | 0.9900 |
| 8:11984415:T:A | acceptor_gain | 0.9700 |
| 8:11984419:A:AG | acceptor_gain | 0.9700 |
| 8:11984420:G:GG | acceptor_gain | 0.9700 |
| 8:11984416:G:A | acceptor_gain | 0.9500 |
| 8:11984420:GGT:G | acceptor_gain | 0.9300 |
| 8:11982380:ACCAG:A | donor_loss | 0.9200 |
| 8:11982381:CCAG:C | donor_loss | 0.9200 |
| 8:11982382:CAG:C | donor_loss | 0.9200 |
| 8:11982383:AG:A | donor_loss | 0.9200 |
| 8:11982384:GGT:G | donor_loss | 0.9200 |
| 8:11982385:GT:G | donor_loss | 0.9200 |
| 8:11982386:T:G | donor_loss | 0.9200 |
| 8:11982570:G:GT | donor_gain | 0.8800 |
| 8:11982387:A:C | donor_loss | 0.7600 |
| 8:11984419:AG:A | acceptor_gain | 0.7500 |
| 8:11984420:GG:G | acceptor_gain | 0.7500 |
| 8:11982353:G:GA | donor_gain | 0.7400 |
| 8:11982500:A:T | donor_gain | 0.6900 |
| 8:11982569:GGAG:G | donor_gain | 0.6700 |
| 8:11982392:G:GT | donor_gain | 0.6600 |
| 8:11984424:G:GA | acceptor_gain | 0.6500 |
| 8:11982598:GT:G | donor_gain | 0.6300 |
| 8:11982599:TT:T | donor_gain | 0.6300 |
| 8:11982601:A:AG | donor_gain | 0.6200 |
| 8:11984423:A:AG | acceptor_gain | 0.6100 |
| 8:11982625:TG:T | donor_gain | 0.5700 |
AlphaMissense
487 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:11984470:G:C | W38C | 0.947 |
| 8:11984470:G:T | W38C | 0.947 |
| 8:11984480:G:T | G42C | 0.943 |
| 8:11984528:T:A | C58S | 0.915 |
| 8:11984529:G:C | C58S | 0.915 |
| 8:11984546:T:A | C64S | 0.894 |
| 8:11984547:G:C | C64S | 0.894 |
| 8:11984529:G:A | C58Y | 0.893 |
| 8:11984498:T:A | C48S | 0.884 |
| 8:11984499:G:C | C48S | 0.884 |
| 8:11984466:G:A | C37Y | 0.883 |
| 8:11984549:T:A | C65S | 0.880 |
| 8:11984550:G:C | C65S | 0.880 |
| 8:11984548:C:G | C64W | 0.877 |
| 8:11984498:T:C | C48R | 0.876 |
| 8:11984465:T:A | C37S | 0.874 |
| 8:11984466:G:C | C37S | 0.874 |
| 8:11984547:G:A | C64Y | 0.871 |
| 8:11984467:T:G | C37W | 0.866 |
| 8:11984456:T:C | F34L | 0.862 |
| 8:11984458:T:A | F34L | 0.862 |
| 8:11984458:T:G | F34L | 0.862 |
| 8:11984530:T:G | C58W | 0.861 |
| 8:11984480:G:C | G42R | 0.858 |
| 8:11984528:T:C | C58R | 0.858 |
| 8:11984550:G:A | C65Y | 0.855 |
| 8:11984486:T:A | C44S | 0.850 |
| 8:11984487:G:A | C44Y | 0.850 |
| 8:11984487:G:C | C44S | 0.850 |
| 8:11984529:G:T | C58F | 0.850 |
dbSNP variants (sampled 300 via entrez): RS1000659324 (8:11982467 A>T), RS1001011821 (8:11982693 T>C), RS1001315518 (8:11982935 A>T), RS1002066852 (8:11983443 C>T), RS1002307156 (8:11984095 C>A,G), RS1002678421 (8:11980965 T>G), RS1003015708 (8:11984752 G>A,C), RS1003347527 (8:11984942 C>A,T), RS1003518128 (8:11981168 C>G), RS1003716227 (8:11981644 G>A), RS1003830876 (8:11983848 T>A), RS1004832887 (8:11984905 C>A,G), RS1005138837 (8:11980501 G>A,C), RS1006269825 (8:11980265 C>A), RS1006706317 (8:11982525 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
21 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004625_106 | Monocyte count | 3.000000e-09 |
| GCST005896_75 | Non-melanoma skin cancer | 4.000000e-08 |
| GCST007709_220 | General factor of neuroticism | 1.000000e-08 |
| GCST007709_251 | General factor of neuroticism | 5.000000e-09 |
| GCST007709_63 | General factor of neuroticism | 3.000000e-11 |
| GCST010002_269 | Refractive error | 1.000000e-24 |
| GCST010142_4 | Fish- and plant-related diet | 2.000000e-12 |
| GCST010142_6 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010142_63 | Fish- and plant-related diet | 2.000000e-12 |
| GCST010142_67 | Fish- and plant-related diet | 1.000000e-10 |
| GCST010142_70 | Fish- and plant-related diet | 8.000000e-10 |
| GCST010142_89 | Fish- and plant-related diet | 4.000000e-16 |
| GCST010142_90 | Fish- and plant-related diet | 7.000000e-15 |
| GCST010703_306 | Brain morphology (MOSTest) | 5.000000e-26 |
| GCST012226_749 | Waist circumference adjusted for body mass index | 3.000000e-08 |
| GCST012228_427 | Waist-hip index | 2.000000e-09 |
| GCST012230_58 | Waist-to-hip ratio adjusted for BMI | 7.000000e-09 |
| GCST012231_98 | A body shape index | 2.000000e-08 |
| GCST90020024_156 | A body shape index | 1.000000e-10 |
| GCST90020029_980 | Waist circumference adjusted for body mass index | 6.000000e-11 |
| GCST90020029_981 | Waist circumference adjusted for body mass index | 3.000000e-08 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005091 | monocyte count |
| EFO:0009260 | non-melanoma skin carcinoma |
| EFO:0007660 | neuroticism measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Phthalic Acids | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.